AEGR

Aegerion Pharmaceuticals, Inc. Press Releases

$22.53
*  
0.28
1.23%
Get AEGR Alerts
*Delayed - data as of Dec. 22, 2014 13:19 ET  -  Find a broker to begin trading AEGR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AEGR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
12/8/2014 8:35:00 AM - GlobeNewswire


Aegerion Pharmaceuticals to Present at the Deutsche Bank BioFEST Conference
11/21/2014 8:30:00 AM - GlobeNewswire


Hynes Keller & Hernandez, LLC Announces Investigations of M/A-Com Technology Solutions Holdings, Inc., Stericycle, Inc. and Aegerion Pharmaceuticals, Inc.
11/13/2014 8:23:00 AM - PR Newswire
▲5.73 % Price Change since this news event. The Volume Ratio is 0.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
11/12/2014 4:10:00 PM - GlobeNewswire


Aegerion Pharmaceuticals Acquires Myalept(TM) From AstraZeneca
11/6/2014 2:10:00 AM - GlobeNewswire


AEGERION ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Aegerion Pharmaceuticals, Inc.
10/31/2014 4:43:00 PM - Business Wire
▲10.99 % Price Change since this news event. The Volume Ratio is 0.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aegerion Pharmaceuticals Announces Third-Quarter 2014 Financial Results
10/30/2014 4:05:00 PM - GlobeNewswire


Aegerion Pharmaceuticals to Announce Third-Quarter 2014 Financial Results on Thursday, October 30
10/27/2014 8:00:00 AM - GlobeNewswire


Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
10/8/2014 4:05:00 PM - GlobeNewswire


Aegerion Pharmaceuticals Announces Presentation at the Leerink Rare Disease Roundtable
9/24/2014 4:10:00 PM - GlobeNewswire


Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day
9/24/2014 9:00:00 AM - GlobeNewswire